Serum uric acid levels of patients with multiple sclerosis and other neurological diseases

Multiple Sclerosis

Volumn 14, Issue 2, 2008, Pages 188-196

  Peng, Fuhua ^a   Zhang, Bin ^a   Zhong, Xiufeng ^b   Li, Jin ^a   Xu, Guihong ^a   Hu, Xueqiang ^a   Qiu, Wei ^a   Pei, Zhong ^c  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

multiple sclerosis; neuroprotection; other neurological diseases; treatment; uric acid

Indexed keywords

GADOLINIUM PENTETATE; URIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; CRYPTOCOCCAL MENINGITIS; DERMATOMYOSITIS; DISABILITY SEVERITY; DISEASE CLASSIFICATION; DISEASE DURATION; ENCEPHALITIS; FEMALE; GENDER; GUILLAIN BARRE SYNDROME; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MENINGOENCEPHALITIS; MIGRAINE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; MYELITIS; NEURITIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMYOSITIS; RADIOACTIVITY; SCHOOL CHILD; SUBARACHNOID HEMORRHAGE; TRANSIENT ISCHEMIC ATTACK; TUBERCULOUS MENINGITIS; URIC ACID BLOOD LEVEL; VIRUS MENINGITIS;

ADOLESCENT; ADULT; AGED; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS; FEMALE; HUMANS; MALE; MENINGITIS; MIDDLE AGED; MULTIPLE SCLEROSIS; NEURITIS; PERIPHERAL NERVOUS SYSTEM DISEASES; URIC ACID;

EID: 43149117933     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458507082143     Document Type: Article

References (26)

1. Bagasra O., Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF et al. Activation of the inducible form of nitric oxide synthase in the brain of the patients with multiple sclerosis. Proc Natl Acad Sci USA 1995; 92: 12041-45.
2. Van der Veen RC, Hinton DR, Incardonna F., Hofman FM Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol 1997; 77: 1-7.
3. Hooper DC, Bagasra O., Marini JC, Zborek A., Ohnishi ST, Kean R. et al. Prevention of experimental allergic encephalo-myelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997; 94: 2528-33.
4. Hooper DC, Spitsin S., Kean RB, Champion JM, Dickson GM, Chaudhry I. et al. Uric acid, a natural scavenger of peroxynitrite., in experimental allergic encephalo-myelitis and multiple sclerosis. Proc Natl Acad Sci USA 1998; 95: 675-80.
5. Sotgiu S., Pugliatti M., Sanna A., Sotgiu A., Fois ML, Arru G. et al. Serum uric acid and multiple sclerosis. Neurol Sci 2002; 23: 183-8.
6. Rentzos M., Nikolaou C., Anagnostouli M., Rombosa A., Tsakanikas K., Economoub M. et al. Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg 2006; 108: 527-31.
7. Miller A., Glass-Marmor L., Abraham M., Grossman I., Shapiro S., Galboiz Y. Bio-markers of disease activity and response to therapy in multiple sclerosis. Clin Neurol Neurosurg 2004; 106: 249-54.
8. Drulovic J., Dujmovic I., Stojsavljevic N., Mesaros A., Andjelkovic S., Miljkovic D. et al. Uric acid levels in sera from patients with multiple sclerosis. J Neurol 2001; 248: 121-6.
9. Toncev G., Milicic B., Toncev S., Samardzic G. Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and bloodbrain barrier dysfunction. Ear J Neurol 2002; 9: 221-6.
10. Poser CM, Paty DW, Scheinberg L., McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
11. McDonald WI, Compston A., Edan G., Goodkin D., Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
12. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
13. Kean RB, Spitsin SV, Mikheeva T., Scott GS, Hooper DC The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity. J Immunol 2000; 165: 6511-8.
14. Langemann H., Kabiersch A., Newcombe J. Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis. Eur Neurol 1992; 32 (5): 248-52.
15. Hooper D., Scott G., Zborek A., Mikheeva T., Kean R., Koprowski H. et al. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 2000; 14: 691-8.
16. Scott GS, Cuzzocrea S., Genovese T., Koprowski H., Hooper DC Uric acid protects against secondary damage after spinal cord injury. PNAS 2005; 102: 3483-8.
17. Kastenbauer S., Koedel U., Pfister HW Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. J Infect Dis 1999; 180: 1164-70.
18. Abbott RD, Brand FN, Kannel WB, Castelli WP Gout and coronary heart disease: the Framingham study. J Clin Epidemiol 1988; 41: 237-42.
19. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk of cardiovascular disease and mortality: the Framingham Heart Study. Ann Intern Med 1999; 131: 7-13.
20. Fang J., Alderman MH Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992: National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404-10.
21. Weir CJ, Muir SW, Walters MR, Lees KR Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003; 34: 1951-6.
22. Yu ZF, Bruce-Keller AJ, Goodman Y., Mattson MP Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 1998; 53: 613-25.
23. Kanellis J., Watanabe S., Li JH, Kang DH, Li P., Nakagawa T. et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41: 1287-93.
24. Kanellis J., Johnson RJ Elevated uric acid and ischemic stroke: Accumulating evidence that it is injurious and not neuroprotective. Stroke 2003; 34: 1956-7.
25. Maxwell AJ, Bruinsma KA Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 2001; 38: 1850-8.
26. Peinado MA, Lopez-Ramos JC, Camacho MV, Molina FJ, Martínez-Romero R., Hernández R. et al. Age and sex related serum changes in nitric oxide: Correlations with serological markers. Int J Cardiol 2007, DOI: 10.1016/j.ijcard.2006.08.032